Johanna Olweus (@jolweus) 's Twitter Profile
Johanna Olweus

@jolweus

Group leader & Head of Dept of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital; Professor, Inst. for Clin. Med., University of Oslo

ID: 901748071712923648

linkhttps://www.ous-research.no/olweus/ calendar_today27-08-2017 10:07:48

147 Tweet

520 Takipçi

106 Takip Edilen

ESMO IOTECH (@esmo_iotech) 's Twitter Profile Photo

IOTECH aspires to provide a forum for today's leaders in the field of #ImmunoOncology. We welcome: ➡️pre-clinical/clinical studies ➡️solid/haematological cancers ➡️technological advances that decipher & improve clinical outcomes Get in touch today!

IOTECH aspires to provide a forum for today's leaders in the field of #ImmunoOncology. 

We welcome: 
➡️pre-clinical/clinical studies 
➡️solid/haematological cancers
➡️technological advances that decipher & improve clinical outcomes

Get in touch today!
Alena Gros (@alena_grosvidal) 's Twitter Profile Photo

We are inviting submissions for our Special Issue on Developments in Cell Therapy ESMO IOTECH . Submission deadline: 8 March 2024. Find out more and submit your manuscript ➡️ spkl.io/60154sUYl ESMO IOTECH

We are inviting submissions for our Special Issue on Developments in Cell Therapy <a href="/esmo_iotech/">ESMO IOTECH</a> . Submission deadline: 8 March 2024. Find out more and submit your manuscript ➡️ spkl.io/60154sUYl 
<a href="/esmo_iotech/">ESMO IOTECH</a>
Cancer Grand Challenges (@cancergrand) 's Twitter Profile Photo

Today is #WorldCancerDay. The theme is Close the Care Gap, which is about creating innovative strategies designed to confront health inequities. It's been top of mind at #CancerGrandChallenges, too - cancer inequities was among our 9 newest challenges 👇 bit.ly/3SqQrKz

Today is #WorldCancerDay. The theme is Close the Care Gap, which is about creating innovative strategies designed to confront health inequities. 

It's been top of mind at #CancerGrandChallenges, too - cancer inequities was among our 9 newest challenges 👇 bit.ly/3SqQrKz
Johanna Olweus (@jolweus) 's Twitter Profile Photo

Fantastisk å være en del av MATCHMAKERS team og få et Cancer Grand Challenge Grant til Norden for første gang. Tusen takk til alle støttespillere! Kreftforeningen, ⁦Precision Immunotherapy AllianceNorges forskningsråd⁩ ⁦⁩ ⁦Oslounivsykehus⁩ ⁦UiO - Det medisinske fakultet⁩ ⁦Helse Sør-Øst RHF

Fantastisk å være en del av MATCHMAKERS team og få et Cancer Grand Challenge Grant til Norden for første gang. Tusen takk til alle støttespillere! Kreftforeningen, ⁦<a href="/CoE_PRIMA/">Precision Immunotherapy Alliance</a>⁩ <a href="/forskningsradet/">Norges forskningsråd</a>⁩ ⁦⁩ ⁦<a href="/Oslounivsykehus/">Oslounivsykehus</a>⁩ ⁦<a href="/UniOslo_MED/">UiO - Det medisinske fakultet</a>⁩ ⁦<a href="/helsesorost/">Helse Sør-Øst RHF</a>⁩
Cancer Grand Challenges (@cancergrand) 's Twitter Profile Photo

It was fantastic to catch up with Lillian Siu from the #CancerGrandChallenges Scientific Committee at our #AACR24 stand today (1313). Lillian was recently elected as AACR President-Elect for 2024-2025. Huge congratulations Lillian! 🎉

It was fantastic to catch up with <a href="/lillian_siu/">Lillian Siu</a> from the #CancerGrandChallenges Scientific Committee at our #AACR24 stand today (1313).

Lillian was recently elected as <a href="/AACR/">AACR</a>  President-Elect for 2024-2025. Huge congratulations Lillian! 🎉
Cancer Immunotherapy (@c_imt) 's Twitter Profile Photo

Learn and connect with peers and scientific leaders in an extraordinary retreat setting in Portugal, September 15-18, 2024. Applications are open for post-docs and advanced PhD students with a research focus in cancer cell therapy. Apply by May 31, 2024. cimt.eu/summer-school

Learn and connect with peers and scientific leaders in an extraordinary retreat setting in Portugal, September 15-18, 2024. 
Applications are open for post-docs and advanced PhD students with a research focus in cancer cell therapy. Apply by May 31, 2024. cimt.eu/summer-school
Iannis Aifantis (@iannisaifantis1) 's Twitter Profile Photo

#AACR2024 don’t miss the first ever heme malignancies micro environment session this morning at 10.15am!! Room 15 at the Mezzanine Level!!!

#AACR2024 don’t miss the first ever heme malignancies micro environment session this morning at 10.15am!! Room 15 at the Mezzanine Level!!!
Sigrid Bratlie (@sigridbratlie) 's Twitter Profile Photo

I spørsmålet om Kjerkols tillit: hvorfor diskuteres ikke mer om hvorvidt vi kan ha en statsråd som lyver om sakens faktum i månedsvis? Det må vel være enda viktigere enn selve oppgavefusket (som i seg selv er diskvalifiserende selvsagt)? 🤷‍♀️ aftenposten.no/norge/politikk…

Andreas Laustsen (@andreaslaustsen) 's Twitter Profile Photo

Happy to share that our great collaboration with Cinzia Cantacessi 🇪🇺🇮🇹🇦🇺🇬🇧 has led to a new research article on #nematode-derived #antimicrobial #peptides: csbj.org/article/S2001-… Thanks to James Rooney for his hard work during his PhD and for his exchange with us at DTU Bioengineering!

Cancer Immunotherapy (@c_imt) 's Twitter Profile Photo

Insightful #CIMT2024 session on Tumor Microenvironment and the complex cross-talk between dysregulated myeloid cells (Leila Akkari Karin de Visser The Netherlands Cancer Institute) and dendritic cells (Boettcher Lab TU München) at single cell and spatial level for #cancer prognosis and #immunotherapy

Insightful #CIMT2024 session on Tumor Microenvironment and the complex cross-talk between dysregulated myeloid cells (<a href="/LeilaAkkari1/">Leila Akkari</a> <a href="/deVisserKarin/">Karin de Visser</a> <a href="/NKI_nl/">The Netherlands Cancer Institute</a>) and dendritic cells (<a href="/BoettcherLab/">Boettcher Lab</a> <a href="/TU_Muenchen/">TU München</a>) at single cell and spatial level for #cancer prognosis and #immunotherapy
Cancer Immunotherapy (@c_imt) 's Twitter Profile Photo

#CIMT2024 session in Advancing antibodies: Pushing forward technology for #cancer #immunotherapy via BiSpecific Abs (dimitris skokos Regeneron) Hexamerization-enhanced Abs (@estherbreij Genmab BioNTech SE) and BiSpec Abs targeting neutrophils marjolein van egmond Amsterdam UMC

#CIMT2024 session in Advancing antibodies: Pushing forward technology for #cancer #immunotherapy via BiSpecific Abs (<a href="/dimitrisskokos/">dimitris skokos</a> <a href="/Regeneron/">Regeneron</a>) Hexamerization-enhanced Abs (@estherbreij <a href="/Genmab/">Genmab</a> <a href="/BioNTech_Group/">BioNTech SE</a>) and BiSpec Abs targeting neutrophils <a href="/marjoleinvanegm/">marjolein van egmond</a> <a href="/amsterdamumc/">Amsterdam UMC</a>
Cancer Immunotherapy (@c_imt) 's Twitter Profile Photo

Are you a PhD student or postdoc with a research focus in cellular immunotherapies? Apply by June 14 to present your work, connect with peers and scientific leaders in an extraordinary retreat setting in Portugal. cimt.eu/summer-school

Are you a PhD student or postdoc with a research focus in cellular immunotherapies? Apply by June 14 to present your work, connect with peers and scientific leaders in an extraordinary retreat setting in Portugal. cimt.eu/summer-school
Iannis Aifantis (@iannisaifantis1) 's Twitter Profile Photo

Now LIVE: the inaugural "Biology and Therapy of Myeloid Malignancies Conference" Fusion Conferences taking place May 14-17, 2025 on a beautiful Minoan coast in Crete, Greece. Huge thanks to co-organizer Ross Levine (and Lee Grimes Lab) ! #MyeloidMalignancies25 fusion-conferences.com/conference/180

Now LIVE: the inaugural "Biology and Therapy of Myeloid Malignancies Conference" <a href="/Fusion_Conf/">Fusion Conferences</a> taking place May 14-17, 2025 on a beautiful Minoan coast in Crete, Greece. Huge thanks to co-organizer <a href="/rosslevinemd/">Ross Levine</a> (and <a href="/LeeGrimesLab/">Lee Grimes Lab</a>) ! #MyeloidMalignancies25
fusion-conferences.com/conference/180